DK175111B1 - New substd. di:phenyl-methylamine derivs. - Google Patents

New substd. di:phenyl-methylamine derivs. Download PDF

Info

Publication number
DK175111B1
DK175111B1 DK199300143A DK14393A DK175111B1 DK 175111 B1 DK175111 B1 DK 175111B1 DK 199300143 A DK199300143 A DK 199300143A DK 14393 A DK14393 A DK 14393A DK 175111 B1 DK175111 B1 DK 175111B1
Authority
DK
Denmark
Prior art keywords
formula
alkyl
peptide
resin
amino acid
Prior art date
Application number
DK199300143A
Other languages
Danish (da)
Other versions
DK14393D0 (en
DK14393A (en
Inventor
Werner Stueber
Gerhard Breipohl
Jochen Knolle
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19873711866 external-priority patent/DE3711866A1/en
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of DK14393D0 publication Critical patent/DK14393D0/en
Publication of DK14393A publication Critical patent/DK14393A/en
Application granted granted Critical
Publication of DK175111B1 publication Critical patent/DK175111B1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Carboxyalkoxy-substd. diphenylmethylamine derivs. of formula (I) are also new. R1=1-8C alkyl or opt. substd. 6-14C aryl; R2=H or an aminoacid residue in which the amino gp. is protected by a weak acid or base-cleavable gp; R3=H or 1-4C alkyl; Y1-Y9=same or different H, 1-4C alkyl, 1-4C alkoxy or -O(CH2)n-COOH, provided one is -O (CH2)n-COOH; n=1-6. Diphenylmethanol deriv. intermediates of formula (II) are also new. Solid-phase synthesis of peptides of formula (XI) comprises: (i) coupling a cpd. (I; R2 other than H) with a resin; (ii) cleaving the protecting gp. of the aminoacid R2; (iii) coupling stepwise with q-p alpha-aminoacids temporarily protected with base- or weak acid-labile protecting gps. (opt. in activated deriv. form); and (iv) releasing the obtd. peptide P-R2a-NH-R3 (XI) (p=peptide residue from q less than or equal to p+1 amino acids; and R2a=aminoacid residue) from the resin with moderately strong acid, with simultaneous or separate cleavage of side-chain protecting gps.

Description

DK 175111 B1 iDK 175111 B1 i

Opfindelsen angår en fremgangsmåde til fremstilling af peptidamider ved en fastfasesyntese samt anvendelsen af diphenylmethanderivater ved syntesen som afstandsgivere (spacere).The invention relates to a process for the preparation of peptidamides in a solid phase synthesis and to the use of diphenylmethane derivatives in the synthesis as spacers.

5 Til fremstillingen af peptidamider ved fastfasesyntese anvendes i almindelighed benzhydrylamin- eller methylbenzhy-drylaminharpikser, såsom de, der f.eks. er beskrevet af J.P. Tam et al., Tetrahedron Lett. 22.» 2851 (1981). En yderligere metode består i ammonolyse af bærestofbundne peptid-10 benzylestere (C. Ressler et al., J. Am. Chem. Soc. 76, 3107 (1951)). Begge metoder er karakteriseret ved den til fra-spaltning af spaceren nødvendige stærke syre (flydende hydrogenfluorid eller trifluormethansulfonsyre), bireaktioner eller ufuldstændig fraspaltning.For the preparation of peptide amides by solid phase synthesis, benzhydrylamine or methylbenzhydrylamine resins such as those used in e.g. is described by J.P. Tam et al., Tetrahedron Lett. 22. »2851 (1981). A further method consists in ammonolysis of carrier-bound peptide-10 benzyl esters (C. Ressler et al., J. Am. Chem. Soc. 76, 3107 (1951)). Both methods are characterized by the strong acid required for decomposition of the spacer (liquid hydrogen fluoride or trifluoromethanesulfonic acid), side reactions or incomplete decomposition.

15 Det er opfindelsens formål at tilvejebringe en frem gangsmåde til fremstilling af peptidamider ved anvendelse af afstandsgivere, der muliggør en mildere og bedre fraspaltning af peptidamider fra bsreharpiksen.It is an object of the invention to provide a process for the preparation of peptide amides using spacers enabling a milder and better cleavage of peptide amides from the resin resin.

Dette er ifølge opfindelsen opnået ved som afstands-20 givere at anvende diphenylmethanderivater med den almene formel IThis is achieved according to the invention by using as spacers the diphenylmethane derivatives of the general formula I

R2 r3 25 YB γ9 γΐ γ2 (i) γ7 γ6 γ5 γ4 i hvilken 30 R1 betyder C^-g-alkyl eller eventuelt substitueret C6.14-aryl, R2 betyder en aminosyrerest, der er beskyttet med en svagt surt eller basisk fraspaltelig aminobeskyttelsesgruppe, R3 betyder hydrogen eller C1_4-alkyl, 35 Y1, Y2, Y3, Y4, Y5, Y6, Y7, Y8 og Y9 betyder hydrogen, C1_4-alkyl, C1«4-alkoxy eller -O-(CH2)n-COOH, hvor grupperne 2 DK 175111 B1 kan være ens eller forskellige, idet én gruppe dog er -0-(CH2)n-COOH, og n betyder et helt tal fra 1 til 6.R2 is Y5 γ9 γΐ γ2 (i) γ7 γ6 γ5 γ4 in which R1 is C1-6 alkyl or optionally substituted C6.14 aryl, R2 is an amino acid residue protected by a weakly acidic or base-leaving amino protecting group R 3 represents hydrogen or C 1-4 alkyl, Y 1, Y 2, Y 3, Y 4, Y 5, Y 6, Y 7, Y 8 and Y 9 means hydrogen, C 1-4 alkyl, C 1-4 alkoxy or -O- (CH 2) n -COOH, wherein the groups 2 may be the same or different, with one group being, however, -0- (CH2) n -COOH, and n means an integer from 1 to 6.

Opfindelsen angår i overensstemmelse hermed anvendel-5 sen af et diphenylmethanderivat med formlen I ved fastfase-syntese af peptidamider med formlen XIThe invention accordingly relates to the use of a diphenylmethane derivative of formula I in the solid phase synthesis of peptidamides of formula XI

P-R2-NH-R3 (XI) 10 i hvilken P betyder en peptidrest af q S p+1 a-aminosyrer, og R2 og R3 er som defineret ovenfor.P-R2-NH-R3 (XI) 10 in which P represents a peptide residue of q S p + 1 α-amino acids and R2 and R3 are as defined above.

Opfindelsen angår desuden en fremgangsmåde til fremstilling af et peptid med formlen XI, i hvilken P, R2 og R3 er som ovenfor defineret, ved en fastfasesyntese, hvilken 15 fremgangsmåde er ejendommelig ved, man med i peptidkemien gængse koblingsreagenser kobler et diphenylmethanderivat med formlen I til en harpiks via -O- (CH2) n-COOH-grupper ingen, fraspalter beskyttelsesgruppen for aminosyren R2, trinvis tilkobler q-p α-aminosyrer, soro er midlertidigt beskyttet 20 med baselabile eller mod svage syrer labile aminobeskyttel-sesgrupper, eventuelt i form af deres aktiverede derivater, og efter endt opbygning frigør peptidet med formlen XI fra harpiksen ved behandling med en middelstærk syre, idet man samtidig eller derefter ved hjælp af egnede foranstaltninger 25 igen fraspalter midlertidigt indførte sidekædebeskyttelses-grupper.The invention further relates to a process for the preparation of a peptide of formula XI, wherein P, R2 and R3 are as defined above, in a solid phase synthesis which is characterized by coupling a diphenylmethane derivative of formula I to the coupling reagents common in the peptide chemistry. a resin via -O- (CH2) n -COOH groups none, cleaves the protecting group for amino acid R2, incrementally connects qp α-amino acids, soro is temporarily protected by base-labile or weak acids labile amino-protecting groups, optionally in the form of their activated derivatives, and upon completion, the peptide of formula XI releases from the resin by treatment with a medium acid, while temporarily or subsequently, by appropriate measures 25, temporarily decomposing side chain protecting groups.

Såfremt det er nødvendigt til hindring af sidereaktioner eller til syntesen af specielle peptider, er de funktionelle grupper i aminosyrernes sidekæde yderligere beskyt-30 tet med egnede beskyttelsesgrupper (jf. f.eks. T.W. Greene, "Protective Groups in Organic Synthesis", New York, John Wiley & Sons, 1981), hvorved der først og fremmest anvendes Arg(Tos), Arg(Mts), Arg(Mtr), Asp(OBzl), Asp(OBut), Cys(4-MeBzl), Cys(Acm), Cys(SBut), Glu(OBzl), Glu(OBut), His(Tos), 35 His(Fmoc), His(Dnp), His(Trt), Lys(Cl-2), Lys(Boc), Met(O), Ser(Bzl), Ser(But), Thr(Bzl), Thr(But).If necessary to prevent side reactions or to the synthesis of particular peptides, the functional groups in the amino acid side chain are further protected by suitable protecting groups (cf., for example, TW Greene, "Protective Groups in Organic Synthesis", New York , John Wiley & Sons, 1981), using primarily Arg (Tos), Arg (Mts), Arg (Mtr), Asp (OBzl), Asp (OBut), Cys (4-MeBzl), Cys (Acm ), Cys (SBut), Glu (OBzl), Glu (OBut), His (Tos), His (Fmoc), His (Dnp), His (Trt), Lys (Cl-2), Lys (Boc), With (O), Ser (Bzl), Ser (But), Thr (Bzl), Thr (But).

3 DK 175111 B13 DK 175111 B1

Foretrukne er forbindelser ned den alnene formel I, 1 hvilken R1 betyder methyl, og n betyder et helt tal på 1, 2 eller 3.Preferred are compounds down to the general formula I, wherein R 1 is methyl and n is an integer of 1, 2 or 3.

Ligeledes foretrukne er forbindelser med denne almene 5 formel I, i hvilken R2 betyder en aminosyrerest, der er beskyttet med en urethanbeskyttelsesgruppe, især FmoC, og R3 betyder hydrogen.Also preferred are compounds of this general Formula I in which R 2 represents an amino acid residue protected with a urethane protecting group, especially FmoC, and R 3 is hydrogen.

Endvidere betyder grupperne Υ3-Υ9 især methyl eller methoxy, idet dog én gruppe betyder -O-(CH2)n-COOH, og mindst 10 4 af disse grupper betyder hydrogen.Furthermore, the groups Υ3-Υ9 mean especially methyl or methoxy, however, one group means -O- (CH2) n -COOH, and at least 10 4 of these groups mean hydrogen.

Fortrinsvis betyder Y1, Y3, Y5, Y7 eller Y8 gruppen -0-(CH2)n-C00H.Preferably, Y1, Y3, Y5, Y7 or Y8 represent the group -O- (CH2) n-C00H.

Alkyl og alkoxy kan være ligekædet eller forgrenet. Cg_i4-Aryl er f.eks. phenyl, naphthyl, biphenylyl 15 eller fluorenyl; fortrinsvis phenyl.Alkyl and alkoxy may be straight or branched. Cg_i4-Aryl is e.g. phenyl, naphthyl, biphenylyl or fluorenyl; preferably phenyl.

R2 betyder resten af en aminosyre, fortrinsvis en a-aminosyre, der, såfremt den er chiral, kan foreligge i D-eller L-formen. Foretrukne er rester af naturligt forekommende aminosyrer og drees enantiomere, homologe, derivater 20 og enkle metaboliter (jf. f.eks. Wunsch et al., Houben-Weyl 15/1 og 2, Stuttgart, Thieme 1974). I betragtning kommer således f.eks.:R 2 means the remainder of an amino acid, preferably an α-amino acid, which, if chiral, may be in the D or L form. Preferred are residues of naturally occurring amino acids and enantiomers, homologues, derivatives 20 and simple metabolites (cf. e.g., Wunsch et al., Houben-Weyl 15/1 and 2, Stuttgart, Thieme 1974). For example:

Aad, Abu, Tf Abu, ABz, 2ABz, eAca, Ach, Acp, Adpd, Ahb, Aib, /3Aib, Ala, /3Ala, AAla, Alg, All, Ama, Amt, Ape, Apm, Apr, 25 Arg, Asn, Asp, Asu, Aze, Azi, Bai, Bph, Can, Cit, Cys, Cyta,Aad, Abu, Tf Abu, ABz, 2ABz, eAca, Ach, Acp, Adpd, Ahb, Aib, / 3Aib, Ala, / 3Ala, AAla, Alg, All, Ama, Amt, Ape, Apm, Apr, 25 Arg, Asn, Asp, Asu, Aze, Azi, Bai, Bph, Can, Cit, Cys, Cyta,

Daad, Dab, Dadd, Dap, Dapm, Dasu, Djen, Dpa, Dtc, Fel, Gin,Daad, Dab, Dadd, Dap, Dapm, Dasu, Djen, Dpa, Dtc, Fel, Gin,

Glu, Gly, Guv, hCys, His, hSer, Hyl, Hyp, 3Hyp, Ile, Ise,Glu, Gly, Guv, hCys, His, hSer, Hyl, Hyp, 3Hyp, Ile, Ise,

Iva, Kyn, Lånt, Len, Leu, Lsg, Lys, ØLys, ALys, Met, Mim, ' Min, nArg, Nle, Nva, Oly, Om, Pan, Pec, Pen, Phe, Phg, 30 Pic, Pro, APro, Pse, Pya, Pyr, Pza, Qin, Ros, Sar, See,Iva, Gender, Borrowed, Len, Leu, Lsg, Light, Ølys, ALys, Met, Mim, 'Min, nArg, Nle, Nva, Oly, Om, Pan, Pec, Pen, Phe, Phg, 30 Pic, Pro, APro, Pse, Pya, Pyr, Pza, Qin, Ros, Sar, See,

Sem, Ser, Thi, ØThi, Thr, Thy, Thx, Tia, Tle, Tly, Trp,Sem, Ser, Thi, Øthi, Thr, Thy, Thx, Tia, Tle, Tly, Trp,

Trta, Tyr, Val samt resterne af de tilsvarende enantiomere D-aminosyrer.Trta, Tyr, Val and the residues of the corresponding enantiomeric D-amino acids.

Funktionelle grupper i de nævnte aminosyreresters 35 sidekæder kan være beskyttede. Egnede beskyttelsesgrupper er beskrevet af Hubbuch, Kontakte (Merck) 1979. nr. 3, side 4 DK 175111 B1 14-23, og Bullesbach, Kontakte (Merck), 1980. nr. 1, side 23-35.Functional groups in the side chains of said amino acid residues may be protected. Suitable protecting groups are described by Hubbuch, Kontakte (Merck) 1979. No. 3, page 4 DK 175111 B1 14-23, and Bullesbach, Kontakte (Merck), 1980. No. 1, pages 23-35.

Baselabile eller mod svage syrer labile beskyttelsesgrupper er især urethanbeskyttelsesgrupper, såsom Fmoc, 5 Ddz, Bpoc, Msc, Peoc, Pse og Tse, fortrinsvis Fmoc (jf. f.eks. Hubbuch, Kontakte (Merck) 1979. nr. 3, side 14-23).Basically labile or weakly acid labile protecting groups are especially urethane protecting groups such as Fmoc, 5 Ddz, Bpoc, Msc, Peoc, Pse and Tse, preferably Fmoc (cf. e.g. Hubbuch, Kontakte (Merck) 1979. No. 3, page 14 -23).

De ved den her omhandlede fremgangsmåde anvendte diphenylmethanderivater fremstilles ved, atThe diphenylmethane derivatives used in this process are prepared by:

a) en benzhydrol med formlen IIa) a benzhydrol of formula II

10 YB γ9 γ1 γ210 YB γ9 γ1 γ2

γ7 γ6 γ5 γ Aγ7 γ6 γ5 γ A

15 i hvilken R1, Y1, Y2, Υ3, Υ4, Υ5, Υ6, Υ7, Υ8 og Υ9 har den ovenfor angivne betydning,15 in which R1, Y1, Y2, Υ3, Υ4, Υ5, Υ6, Υ7, Υ8 and Υ9 have the meaning given above,

omsættes med en forbindelse med formlen IIIreact with a compound of formula III

20 R2 R3 \ / N (III)R2 R3 / N (III)

25 I25 I

HH

i hvilken R2 betyder hydrogen eller en aminosyrerest, der er beskyttet 30 med en svagt surt eller basisk fraspaltelig aminobeskyttel-sesgruppe, og R3 betyder hydrogen eller C1_4-alkyl, ellerin which R 2 represents hydrogen or an amino acid residue protected by a weakly acidic or basic leaving amino protecting group and R 3 represents hydrogen or C 1-4 alkyl, or

b) en benzophenon med formlen IVb) a benzophenone of formula IV

35 γΒ γ90 γΐ γ2 γ7 γ6 γδ γ4 (IV) 5 DK 175111 B135 γΒ γ90 γΐ γ2 γ7 γ6 γδ γ4 (IV) 5 DK 175111 B1

omsættes med hydroxylamin til en forbindelse med formlen Vis reacted with hydroxylamine to a compound of formula V

OHOH

YB γ9 I γΐ γ2 5 R1 Y7 γ6 γ5 γ4 i hvilken R1, Υ1, Υ2, Υ3, Υ4, Υ5, Υ6, Υ7, Υ8 og Υ9 er defineret som ovenfor, 10 hvorefter oximen reduceres til en amin, fortrinsvis med zink i iseddikesyre (S. Gaehde, G. Matsueda, Int. J. Peptide Protein Res. 18, 451 (1981)), og aminen eventuelt omdannes til derivater heraf.YB γ9 In γΐ γ2 5 R1 Y7 γ6 γ5 γ4 in which R1, Υ1, Υ2, Υ3, Υ4, Υ5, Υ6, Υ7, Υ8 and Υ9 are defined as above, after which the oxime is reduced to an amine, preferably with zinc in glacial acetic acid. (S. Gaehde, G. Matsueda, Int. J. Peptide Protein Res. 18, 451 (1981)) and the amine optionally converted to derivatives thereof.

Hidtil ukendte diphenylmethanderivater med formlen 15 I, hvor R2 foruden at have den ovenfor angivne betydning også kan betyde hydrogen, fremgangsmåden til deres fremstilling og de hidtil ukendte benzhydrolderivater med formlen II er genstand for patentkrav i stamansøgningen, DK nr. 1893/88-A, hvor fremgangsmåden også er belyst mere detal-20 jeret.New diphenylmethane derivatives of formula I, wherein R 2, in addition to having the meaning given above, may also mean hydrogen, the process for their preparation and the novel benzhydrol derivatives of formula II are subject to claims in the parent application, DK No. 1893/88-A, wherein the method is also elucidated in more detail.

De som bæremateriale anvendte harpikser kan fås kommercielt eller er separat fremstillet, såsom alkoxybenzylal-koholharpikser, aroinomethylharpikser eller benzhydrylamino-harpikser. Foretrukne er benzhydrylamino- (BHA) og methyl-25 benzhydrylamino-harpikser (MBHA). Belastningen bestemmes ved aminosyreanalyse og/eller elementaranalyse.The resins used as the carrier material can be obtained commercially or are manufactured separately, such as alkoxybenzyl alcohol resins, aroinomethyl resins or benzhydrylamino resins. Preferred are benzhydrylamino (BHA) and methylbenzhydrylamino (MBHA) resins. The load is determined by amino acid analysis and / or elemental analysis.

Som koblingsreagens for diphenylmethanderivatet med formlen I og for de yderligere aminosyrederivater kan der anvendes alle mulige i peptidsyntesen anvendte aktiverings-30 reagenser, jf. f.eks. Houben-Weyl, Methoden der organischen Chemie, bind 15/2, især dog carbodiimider, såsom Ν,Μ'-dicy-clohexylcarbodiimid, N,N'-diisopropylcarbodiimid eller N--ethyl-N'-(3-dimethylaminopropyl)-carbodiimid. Koblingen til harpiksen kan derved gennemføres direkte ved addition af et 35 aminosyrederivat med et aktiveringsreagens, og eventuelt med en tilsætning, der undertrykker racemisering, f.eks. 4- 6 DK 175111 B1 dimethylaminopyridin, 1-hydroxybenzotriazol (HOBt) (W. Konig, R. Geiger, Chein. Ber. 103. 708 (1970)) eller 3-hydroxy-4-oxo-3,4-dihydrobenzotriazin (HOObt) (W. Konig, R. Geiger,As the coupling reagent for the diphenylmethane derivative of formula I and for the additional amino acid derivatives all possible activating reagents used in peptide synthesis can be used, cf. Houben-Weyl, The Method of Organic Chemistry, Vol. 15/2, especially, however, carbodiimides such as Μ, d'-dicyclohexylcarbodiimide, N, N'-diisopropylcarbodiimide or N - ethyl-N '- (3-dimethylaminopropyl) carbodiimide . The coupling to the resin can thereby be effected directly by the addition of a 35 amino acid derivative with an activating reagent, and optionally with an addition which suppresses racemization, e.g. 4-6 DK 175111 B1 dimethylaminopyridine, 1-hydroxybenzotriazole (HOBt) (W. Konig, R. Geiger, Chein. Ber. 103. 708 (1970)) or 3-hydroxy-4-oxo-3,4-dihydrobenzotriazine (HOObt ) (W. Konig, R. Geiger,

Chen. Ber. 103. 2054 (1970)), eller også kan foraktiveringen 5 af aminosyrederivatet son synnetrisk anhydrid eller HOBt-eller HOObt-ester udfores separat, og opløsningen af de aktiverede naterialer i et egnet opløsningsmiddel sættes til en koblingsdygtig peptidharpiks.Chen. Ber. 103. 2054 (1970)) or alternatively, the pre-activation of the amino acid derivative such as synnetic anhydride or HOBt or HOObt ester can be carried out separately and the solution of the activated materials in a suitable solvent is added to a coupled peptide resin.

Koblingen eller aktiveringen af en forbindelse ned 10 formlen I og af aminosyrederivaterne ned et af de ovenfor nævnte aktiveringsreagenser kan gennemføres i dimethylform-amid eller methylenchlorid eller en blanding af begge. Det aktiverede aninosyrederivat anvendes i almindelighed i et 1,5 til 4-dobbelt overskud. I de tilfælde, hvor der optræder 15 en ufuldstændig kobling, gentages koblingsreaktionen uden først at gennemføre den til koblingen af den efterfølgende aminosyre nødvendige afblokering af peptidharpiksens a-amino-syregruppe.The coupling or activation of a compound down the formula I and of the amino acid derivatives down one of the activation reagents mentioned above can be carried out in dimethylformamide or methylene chloride or a mixture of both. The activated amino acid derivative is generally used in a 1.5 to 4-fold excess. In cases where an incomplete coupling occurs, the coupling reaction is repeated without first performing the unblocking required of the subsequent amino acid by the α-amino acid group of the peptide resin.

Det vellykkede forløb af koblingsreaktionen kan under-20 søges ved hjælp af ninhydrin-reaktionen, f.eks. som beskrevet af E. Kaiser et al., Anal. Biochem. Μ» 595 (1970). Syntesen kan også gennemføres automatisk, f.eks. med en peptidsynte-tisator model 430A fra Applied Biosystems, hvorved der enten kan anvendes de fra apparatfremstilleren fastlagte syntese-25 programmer eller også af brugeren selv fremstillede synteseprogrammer. Sidstnævnte anvendes især ved anvendelse af med Fmoc-gruppen beskyttede aminosyrederivater.The successful course of the coupling reaction can be investigated by means of the ninhydrin reaction, e.g. as described by E. Kaiser et al., Anal. Biochem. 5 »595 (1970). The synthesis can also be performed automatically, e.g. with a peptide synthesizer model 430A from Applied Biosystems, whereby either the synthesis programs established by the device maker or the user's own synthesis programs can be used. The latter is particularly used when using amino acid derivatives protected with the Fmoc group.

Fraspaltningen af peptidamiderne fra harpiksen sker ved behandling med i peptidsyntesen gængs anvendte, mid-30 delstærke syrer (f.eks. trifluoreddikesyre), hvorved der som kationbinder anvendes sådanne substanser som phenol, cresol, thiocresol, anisol, thioanisol, ethandithiol, dime-thylsulfid, ethylmethylsulfid eller lignende, i fastfasesyn-tesen gængse kationbindere, idet disse anvendes enkeltvis 35 eller som en blanding af to eller flere af disse hjælpestoffer. Trifluoreddikesyren kan også anvendes fortyndet med 7 DK 175111 B1 egnede opløsningsmidler, såsom methylenchlorid.The cleavage of the peptide amides from the resin is effected by treatment with commonly used, medium-strong acids (e.g. trifluoroacetic acid) used in the peptide synthesis, using as cationic linkers such substances as phenol, cresol, thiocresol, anisole, thioanisole, ethanedithiol, dimethyldiol , ethyl methyl sulfide or the like, in the solid phase synthesis common cation binders, used singly or as a mixture of two or more of these excipients. The trifluoroacetic acid may also be used diluted with suitable solvents such as methylene chloride.

Ved fraspaltningen af spaceren fra harpiksen udføres fraspaltningen af sidekædebeskyttelsesgrupperne samtidig.Upon splitting the spacer from the resin, the splitting of the side chain protecting groups is performed simultaneously.

Oprensningen af de således opnåede råpeptider udføres 5 ved hjælp af chromatografi på nSephadex®"-ionbytterharpikser eller ved HPLC.The purification of the crude peptides thus obtained is carried out by chromatography on nSephadex® ion exchange resins or by HPLC.

Nedenstående eksempler tjener til illustration af den ovenfor beskrevne opfindelse.The following examples serve to illustrate the invention described above.

10 Eksempel 1 4-(4·-Methoxybenzoyl)-phenoxyeddikesyrernethylester.Example 1 4- (4-Methoxybenzoyl) -phenoxyacetic acid ethyl ester.

64 g aluminiumchlorid (vandfrit) opløses i 160 ml 1,2-dichlorethan, og hertil sættes 71,6 g 4-methoxybenzoyl-chlorid. Hertil dryppes 57,6 ml phenoxyeddikesyremethylester 15 langsomt under omrøring, og reaktionsblandingen opvarmes i 4 timer til 50*C. Blandingen dryppes til isvand, hvorved der udskilles en olie. Vandfasen skilles fra, og remanensen udrøres tre gange med vand, og der krystalliseres med methanol. Udfældningen frafiltreres, og der omkrystalliseres fra 20 ethylacetat.Dissolve 64 g of aluminum chloride (anhydrous) in 160 ml of 1,2-dichloroethane, to which 71.6 g of 4-methoxybenzoyl chloride is added. To this, 57.6 ml of phenoxyacetic acid methyl ester 15 is slowly added with stirring and the reaction mixture is heated to 50 ° C for 4 hours. The mixture is dripped to ice water, which separates an oil. The aqueous phase is separated and the residue is stirred three times with water and crystallized with methanol. The precipitate is filtered off and recrystallized from 20 ethyl acetate.

Udbytte: 54,9 g (53% af teorien).Yield: 54.9 g (53% of theory).

Smeltepunkt: 146'C (148*C, ethylacetat).Melting point: 146 ° C (148 ° C, ethyl acetate).

Eksempel 2 25 4-(4'-Methoxybenzoyl)-phenoxyeddikesyre.Example 2 4- (4'-Methoxybenzoyl) phenoxyacetic acid.

9,0 g af methylesteren fra eksempel 1 opløses i 120 ml 1,2-dimethoxyethan/vand (4:1, vol:vol), og hertil sættes 15 ml 2N NaOH. Blandingen omrøres i 3 timer, hvorefter pH indstilles på 3 med 3 N HC1. Det organiske opløsningsmiddel 30 afdampes under vakuum, og det udfældede produkt frafiltreres, hvorefter det vaskes med vand og tørres under højvakuum.Dissolve 9.0 g of the methyl ester of Example 1 in 120 ml of 1,2-dimethoxyethane / water (4: 1, v: v) and add 15 ml of 2N NaOH. The mixture is stirred for 3 hours, then the pH is adjusted to 3 with 3 N HCl. The organic solvent 30 is evaporated under vacuum and the precipitated product is filtered off, then washed with water and dried under high vacuum.

Udbytte: 8,4 g (98% af teorien).Yield: 8.4 g (98% of theory).

Smeltepunkt: 181-182*C.Melting point: 181-182 ° C.

8 DK 175111 B18 DK 175111 B1

Eksempel 3 (4-Carboxymethoxyphenyl)-4'-methoxyphenylcarbinol.Example 3 (4-Carboxymethoxyphenyl) -4'-methoxyphenylcarbinol.

11,2 g 4-(4'-methoxybenzoyl)-phenoxyeddikesyre opløses i 600 ml 80%'s methanol (tilbagesvaling), og hertil sættes 5 4,4 ml N-methylmorpholin. Til blandingen sættes portionsvis i løbet af 2 timer 6 g natriumborhydrid, og reaktionen videreføres i 3 timer under tilbagesvalingsbetingelser. Blandingen afkøles til stuetemperatur, og den gøres sur med 3 N HC1 til pH 2,5. Methanolet afdestilleres, og den vandige 10 fase ekstraheres med ethylacetat, hvorefter der vaskes med en kogsaltopløsning, og der tørres over natriumsulfat. Efter afdestillering af ethylacetatet bliver et hvidt, amorft pulver tilbage. Produktet anvendes direkte til den næste reaktion. Udbytte: 9,3 g (83% af teorien).Dissolve 11.2 g of 4- (4'-methoxybenzoyl) phenoxyacetic acid in 600 ml of 80% methanol (reflux) and to this add 4.4 ml of N-methylmorpholine. To the mixture, 6 g of sodium borohydride are added portionwise over 2 hours and the reaction is continued for 3 hours under reflux conditions. The mixture is cooled to room temperature and acidified with 3 N HCl to pH 2.5. The methanol is distilled off and the aqueous phase is extracted with ethyl acetate, then washed with a brine and dried over sodium sulfate. After distilling off the ethyl acetate, a white amorphous powder remains. The product is used directly for the next reaction. Yield: 9.3 g (83% of theory).

1515

Eksempel 4 2-Methylphenoxyeddikesyremethylester.Example 4 2-Methylphenoxyacetic acid methyl ester.

108 g 2-methylphenol opløses i 500 ml tør acetone, og hertil sættes 165,8 g pulveriseret kaliumcarbonat. Til 20 den omrørte suspension sættes 113 ml bromeddikesyreroethyles-ter, og blandingen videreomrøres ved stuetemperatur under udelukkelse af fugtighed. Efter afsluttet reaktion frafiltre-res saltet ved sugning, og der eftervaskes med acetone, og filtratet koncentreres. Der optages i ethylacetat, hvorefter 25 der vaskes med vand, og den organiske fase tørres over magnesiumsulfat, og den koncentreres.Dissolve 108 g of 2-methylphenol in 500 ml of dry acetone and add 165.8 g of powdered potassium carbonate. To the stirred suspension is added 113 ml of bromoacetic acid ethyl ester and the mixture is further stirred at room temperature, excluding moisture. After completion of the reaction, the salt is filtered off by suction and washed with acetone and the filtrate is concentrated. It is taken up in ethyl acetate, then washed with water and the organic phase is dried over magnesium sulfate and concentrated.

Udbytte: 180 g af en olieagtig væske, der direkte videreom-sættes. 1 2 3 4 5 6Yield: 180 g of an oily liquid which is directly converted. 1 2 3 4 5 6

Eksempel 5 2 4-(4'-Methoxybenzoyl)-2-methylphenoxyeddikesyremethylester.Example 5 2- 4- (4'-Methoxybenzoyl) -2-methylphenoxyacetic acid methyl ester.

3 146,6 g vandfrit aluminiumtrichlorid opløses i 500 4 ml 1,2-dichlorethan. Ved 0*C dryppes hertil efter hinanden 5 187 g 4-methoxybenzoylchlorid og 180 g 2-methylphenoxyed- 6 dikesyremethylester. Til fuldstændiggørelse af reaktionen opvarmes der til 50*C. Blandingen hældes på is, og pH ind- 9 DK 175111 B1 stilles på 2 med 2 N HCl. Det udfældede produkt frafiltreres ved sugning, og det vaskes med vand og noget ether. Udfældningen opløses under varme i ethylacetat under tilsætning af noget aktivt kul, hvorefter der filtreres, og der krystal-5 liseres ved -10*C. Produktet frafiltreres ved sugning, hvorefter det vaskes med ether, og der tørres under højvakuum. Udbytte: 172,8 g (55% af teorien).3 146.6 g of anhydrous aluminum trichloride are dissolved in 500 4 ml of 1,2-dichloroethane. At 0 ° C, 5 187 g of 4-methoxybenzoyl chloride and 180 g of 2-methylphenoxyacetic acid methyl ester are added dropwise. To complete the reaction, heat to 50 ° C. The mixture is poured onto ice and the pH is adjusted to 2 with 2N HCl. The precipitated product is filtered off by suction and washed with water and some ether. The precipitate is dissolved under heat in ethyl acetate, with the addition of some activated carbon, then filtered and crystallized at -10 ° C. The product is filtered off by suction, washed with ether and dried under high vacuum. Yield: 172.8 g (55% of theory).

Smeltepunkt: 92-95*C.Melting point: 92-95 ° C.

10 Eksempel 6 4-(4'-Methoxybenzoyl)-2-methylphenoxyeddikesyremethylester.Example 6 4- (4'-Methoxybenzoyl) -2-methylphenoxyacetic acid methyl ester.

50 g 4-hydroxy-3-methyl-4'-methoxybenzophenon (R.50 g of 4-hydroxy-3-methyl-4'-methoxybenzophenone (R.

Martin et al., Monatsh. Chemie 110. 1057-1066 (1979)) opløses i 200 ml tørt DMF, og hertil sættes under N2 forsigtigt 9 g 15 af en 55%'s dispersion af natriumhydrid i mineralolie. Til blandingen dryppes herefter under omrøring 19,5 ml bromeddi-kesyremethylester, og blandingen tillades at henstå natten over ved stuetemperatur. Det udfældede salt frafiltreres ved sugning, og filtratet koncentreres under vakuum. Remanen-20 sen optages i ethylacetat, og der vaskes med en natrium-hydrogencarbonatopløsning og vand. Den organiske fase tørres over magnesiumsulfat, og opløsningsmidlet fjernes. Remanensen udrives med ether, hvorefter der frafiltreres ved sugning, og der tørres.Martin et al., Monatsh. Chemie 110. 1057-1066 (1979)) is dissolved in 200 ml of dry DMF, and to this N2 is carefully added 9 g of a 55% sodium hydride dispersion in mineral oil. The mixture is then added dropwise with stirring 19.5 ml of bromoacetic acid methyl ester and the mixture is allowed to stand overnight at room temperature. The precipitated salt is filtered off by suction and the filtrate is concentrated under vacuum. The residue is taken up in ethyl acetate and washed with a sodium hydrogen carbonate solution and water. The organic phase is dried over magnesium sulfate and the solvent is removed. The residue is triturated with ether, then filtered off with suction and dried.

25 Udbytte: 38,9 g (60% af teorien).Yield: 38.9 g (60% of theory).

Smeltepunkt: 96-98*C.Melting point: 96-98 ° C.

Eksempel 7 4-(4'-Methoxybenzoyl)-phenoxyeddikesyremethylester.Example 7 4- (4'-Methoxybenzoyl) phenoxyacetic acid methyl ester.

30 29,1 g 4-hydroxy-4'-methoxybenzophenon (R. Martin et al., Monatsh. Chemie 110. 1057-1066 (1979)) opløses i 400 ml tør acetone. Herefter sætter man under omrøring 19,3 g finpulveriseret K2CO3 og 16 ml bromeddikesyremethylester til blandingen, og den omrøres ved stuetemperatur. Efter 2 35 dage er reaktionen afsluttet. Den udfældede salt-substans-blanding frafiltreres ved sugning, hvorefter filtratet kon- 10 DK 175111 B1 centreres. Begge remanenser suspenderes i vand, og pH indstilles på 3 med 2 N HC1. Der frafiltreres ved sugning, hvorefter der vaskes med vand, og der tørres i exsikkator under højvakuum.29.1 g of 4-hydroxy-4'-methoxybenzophenone (R. Martin et al., Monatsh. Chemie 110. 1057-1066 (1979)) are dissolved in 400 ml of dry acetone. Then, with stirring, 19.3 g of finely powdered K2CO3 and 16 ml of bromacetic acid methyl ester are added to the mixture and it is stirred at room temperature. After 2 35 days, the reaction is complete. The precipitated salt-substance mixture is filtered off by suction, after which the filtrate is concentrated. Both residues are suspended in water and the pH is adjusted to 3 with 2 N HCl. Filtrate by suction, wash with water and dry in desiccator under high vacuum.

5 Udbytte: 35,7 g (98% af teorien).Yield: 35.7 g (98% of theory).

Smeltepunkt: 143-145*C.Melting point: 143-145 ° C.

Eksempel 8 4-(4'-Methoxybenzoyl)-2-methylphenoxyeddikesyre.Example 8 4- (4'-Methoxybenzoyl) -2-methylphenoxyacetic acid.

10 35,8 g 4-(4 '-methoxybenzoyl)-2-methylphenoxyeddikesy- remethylester omrøres med en blanding af 240 ml dioxan og 240 ml 0,5 N NaOH ved stuetemperatur. Efter end reaktion fjernes det organiske opløsningsmiddel, og den vandige fase indstilles på pH 3 med 2 N HC1, hvorefter der ekstraheres 15 med ethylacetat. Der vaskes med vand, hvorefter der tørres over magnesiumsulfat, og der koncentreres. Tilbage bliver der bleggule krystaller.35.8 g of 4- (4'-methoxybenzoyl) -2-methylphenoxyacetic acid methyl ester are stirred with a mixture of 240 ml of dioxane and 240 ml of 0.5 N NaOH at room temperature. After the reaction, the organic solvent is removed and the aqueous phase is adjusted to pH 3 with 2N HCl, then extracted with ethyl acetate. Wash with water, then dry over magnesium sulfate and concentrate. Back there will be pale yellow crystals.

Udbytte: 30,2 g (83% af teorien).Yield: 30.2 g (83% of theory).

Smeltepunkt: 149-151*C.Melting point: 149-151 ° C.

2020

Eksempel 9 (4-Carboxymethoxy-3-methylphenyl)-4'-methoxyphenylcarbinol.Example 9 (4-Carboxymethoxy-3-methylphenyl) -4'-methoxyphenylcarbinol.

22,5 g 4- (4 1 -methoxybenzoyl) -2-methylphenoxyeddikesyre opløses i en blanding af 100 ml dioxan og 200 ml vand under 25 tilsætning af 1 N NaOH til pH 9. Til den omrørte opløsning sættes portionsvis 2,8 g natriumborhydrid, og blandingen tillades at henstå natten over. Derefter fjernes dioxanet, og vandfasen indstilles på pH 3 med 2 N HC1, og der ekstraheres med ethylacetat. Den organiske fase tørres over magne-30 siumsulfat, og der koncentreres. Tilbage bliver et farveløst skum, der udrives med n-hexan til et amorft pulver, hvorefter der frafiltreres ved sugning. Produktet anvendes direkte i den næste reaktion.Dissolve 22.5 g of 4- (4 L -methoxybenzoyl) -2-methylphenoxyacetic acid in a mixture of 100 ml of dioxane and 200 ml of water while adding 1 N NaOH to pH 9. To the stirred solution is added portionwise 2.8 g of sodium borohydride. , and the mixture is allowed to stand overnight. Then the dioxane is removed and the aqueous phase is adjusted to pH 3 with 2N HCl and extracted with ethyl acetate. The organic phase is dried over magnesium sulfate and concentrated. Back is a colorless foam which is rubbed off with n-hexane to an amorphous powder and then filtered off by suction. The product is used directly in the next reaction.

Udbytte: 19,2 g (84% af teorien).Yield: 19.2 g (84% of theory).

35 11 DK 175111 B135 11 DK 175111 B1

Eksempel 10 2.6- Dime thylphenoxyeddikesyremethylester.Example 10 2.6- Dime thylphenoxyacetic acid methyl ester.

65 g 2,6-dimethylphenol opløses i 200 ml tørt DMF, og under N2 sættes portionsvis 23,2 g af en 55%'s suspension 5 af natriumhydrid i mineralolie til blandingen. Herefter dryppes 50,4 ml bromeddikesyremethylester under omrøring til blandingen, og den tillades at henstå natten over. Det udfældede salt frafiltreres ved sugning, og filtratet koncentreres. Remanensen optages i ethylacetat, og der ekstra-10 heres med vand. Den organiske fase tørres over magnesiumsulfat, og den koncentreres. Tilbage bliver en olieagtig væske, der anvendes direkte i den følgende reaktion.Dissolve 65 g of 2,6-dimethylphenol in 200 ml of dry DMF, and under N2, 23.2 g of a 55% suspension of sodium hydride in mineral oil are added portionwise to the mixture. Then, 50.4 ml of bromoacetic acid methyl ester is added dropwise with stirring to the mixture and allowed to stand overnight. The precipitated salt is filtered off by suction and the filtrate is concentrated. The residue is taken up in ethyl acetate and extracted with water. The organic phase is dried over magnesium sulfate and concentrated. Back becomes an oily liquid used directly in the following reaction.

Udbytte: 95,8 g (92% af teorien).Yield: 95.8 g (92% of theory).

15 Eksempel 11 2.6- Dimethyl-4-(4·-methoxybenzoyl)-phenoxyeddikesyremethyl-ester.Example 11 2.6- Dimethyl-4- (4'-methoxybenzoyl) phenoxyacetic acid methyl ester.

Syntesen udføres analogt med eksempel 5 med 19,4 g 2.6- dimethylphenoxyeddikesyremethylester.The synthesis is carried out analogously to Example 5 with 19.4 g of 2,6-dimethylphenoxyacetic acid methyl ester.

20 Udbytte: 17,4 g (53% af teorien).Yield: 17.4 g (53% of theory).

Eksempel 12 (4-Carboxymethoxy-3,5-dimethylphenyl) -4' -methoxyphenylcar-binol.Example 12 (4-Carboxymethoxy-3,5-dimethylphenyl) -4'-methoxyphenylcarbinol.

25 16,4 g 2,6-dimethyl-4-(4 ·-methoxybenzoyl)-phenoxyeddi- kesyremethylester omrøres i en blanding af 100 ml 0,5 N NaOH og 100 ml dioxan ved stuetemperatur. Efter afsluttet forsæbning af methylesteren sættes 1,89 g natriumborhydrid til blandingen, og den tillades at reagere natten over.16.4 g of 2,6-dimethyl-4- (4'-methoxybenzoyl) phenoxyacetic acid methyl ester are stirred in a mixture of 100 ml of 0.5 N NaOH and 100 ml of dioxane at room temperature. After completion of saponification of the methyl ester, 1.89 g of sodium borohydride is added to the mixture and allowed to react overnight.

30 Herefter frafiltreres noget uopløst materiale, hvorefter filtratet koncentreres, og den tilbageblevne, vandige opløsning gøres sur med l N HC1. Der ekstraheres med ethylacetat, hvorefter den organiske fase vaskes med vand, og der tørres over magnesiumsulfat, hvorefter blandingen koncentreres.Then, some undissolved material is filtered off and the filtrate is concentrated and the residual aqueous solution is acidified with 1 N HCl. Extract with ethyl acetate, then wash the organic phase with water and dry over magnesium sulfate, then concentrate the mixture.

35 Tilbage bliver der et amorft pulver, der anvendes direkte til den efterfølgende omsætning.35 Back there will be an amorphous powder used directly for the subsequent turnover.

12 DK 175111 B112 DK 175111 B1

Udbytte: 11,3 g (71% af teorien).Yield: 11.3 g (71% of theory).

Almen forskrift til fremstilling af Na-Fmoc-amino-syre- (4-carboxymethoxy-phenyl-4' -methoxyphenyl) -methylamider samt Ncr-Fmoc-aminosyre-(4-carboxymethoxy-3-methylphenyl-4 5 methoxyphenyl)-methylamider og Na-Fmoc-aminosyre-(4-car-boxymethoxy-3,5-dimethylpheny1-4'-methoxyphenyl)-methylamider.General Specification for the Preparation of Na-Fmoc-Amino Acid (4-Carboxymethoxy-Phenyl-4'-Methoxyphenyl) -methylamides and Ncr-Fmoc-Amino Acid (4-Carboxymethoxy-3-methylphenyl-4-methoxyphenyl) -methylamides and Na-Fmoc amino acid (4-carboxyl-3,5-boxymethoxy dimethylpheny1-4'-methoxyphenyl) -methylamider.

10 mmol Να-Fmoc-aminosyreamid og 10 mmol af den tilsvarende carbinol opløses i den nødvendige msngde vandfri 10 iseddikesyre, og hertil sættes 5-10 dråber koncentreret svovlsyre. Til blandingen sættes endnu 2 g molekylsigte, og blandingen tillades at henstå natten over. Herefter frafil-treres molekylsigten ved sugning, og filtratet fortyndes med meget vand, hvorved produktet delvis udfælder. Den van-15 dige fase ekstraheres med ethylacetat, hvorefter den organiske fase udrystes med vand. Den substans, der bliver tilbage efter tørring over natriumsulfat og koncentrering, omkrystalliseres.10 mmol of Να-Fmoc amino acid amide and 10 mmol of the corresponding carbinol are dissolved in the required amount of anhydrous 10 glacial acetic acid, to which are added 5-10 drops of concentrated sulfuric acid. To the mixture is added another 2 g of molecular sieve and the mixture is allowed to stand overnight. Then the molecular sieve is filtered off by suction and the filtrate is diluted with a lot of water, whereby the product partially precipitates. The aqueous phase is extracted with ethyl acetate, then the organic phase is shaken with water. The substance remaining after drying over sodium sulfate and concentration is recrystallized.

Efter overstående gængse forskrift fremstilles følgen-20 de forbindelser:In accordance with the above conventional regulations, the following compounds are prepared:

Eksempel 13Example 13

He-Pmoc-Glycin- (4-carboxymethoxyphenyl-4' -methoxyphenyl) me-thylamid.He-Pmoc-Glycine (4-carboxymethoxyphenyl-4 '-methoxyphenyl) methylamide.

25 Udbytte: 65%.Yield: 65%.

Smeltepunkt: 136-138*C.Melting point: 136-138 ° C.

Eksempel 14 Νβ-Fmoc-Phenylalanin- (4-carboxymethoxyphenyl-4' -methoxyphe-30 nyl)methylamid.Example 14 β-Fmoc-Phenylalanine (4-carboxymethoxyphenyl-4 '-methoxyphenyl) methylamide.

Udbytte: 65%.Yield: 65%.

Smeltepunkt: 159-162*C.Melting point: 159-162 ° C.

13 DK 175111 B113 DK 175111 B1

Eksempel 15 Να-Fmoc-Glycin-(4-carboxymethoxy-3-methylphenyl-4'-methoxy-phenyl)methylamid.Example 15 Να-Fmoc-Glycine (4-carboxymethoxy-3-methylphenyl-4'-methoxy-phenyl) methylamide.

Udbytte: 60%.Yield: 60%.

5 Smeltepunkt: 135-140*C.Melting point: 135-140 ° C.

Eksempel 16Example 16

Ne-Fmoc-Valin- (4-carboxymethoxy-3-methylphenyl-4' -methoxyphe-ny1)methylamid.Ne-Fmoc-Valin- (4-carboxymethoxy-3-methylphenyl-4'-methoxyphenyl) methylamide.

10 Udbytte: 81%.Yield: 81%.

Smeltepunkt: 172-175*C.Melting point: 172-175 ° C.

Eksempel 17 Να-Fmoc-Glycin- (4-carboxymethoxy-3,5-dimethylphenyl-4' -me-15 thoxyphenyl)methylamid.Example 17? -Α-Fmoc-Glycine (4-carboxymethoxy-3,5-dimethylphenyl-4'-methoxyphenyl) methylamide.

Udbytte: 70%.Yield: 70%.

Smeltepunkt: 122-126*0.Melting point: 122-126 * 0.

Eksempel 18 20 Syntese af oxytocin H-Cys-Tyr-Ile-Gln-Asn-CYs-Pro-Leu-Gly-NHg under anvendelse af det i eksmepel 13 beskrevne anker. Syntesen udføres i et organ til peptidsyntese fra Fa. Labotec.Example 18 Synthesis of oxytocin H-Cys-Tyr-Ile-Gln-Asn-CYs-Pro-Leu-Gly-NHg using the anchor described in Example 13. The synthesis is carried out in a peptide synthesis organ from Fa. Labotec.

25 Fra 1,5 g Boc-Val-harpiks (belastning 0,76 mmol/g) fjernes først beskyttelsesgruppen med trifluoreddikesyre i methylenchlorid. Efter vask med dichlormethan og ethyldiiso-propylamin og igen med dichlormethan tørres harpiksen. Herefter sættes 2,1 mmol af det i eksempel 13 fremstillede 30 anker sammen med 3,15 mmol HOBt opløst i 20 ml tørt DMF til harpiksen, og der tilsættes 2,3 mmol diisopropylcarbodiimid.25 From 1.5 g of Boc-Val resin (loading 0.76 mmol / g), the protecting group with trifluoroacetic acid in methylene chloride is first removed. After washing with dichloromethane and ethyl diisopropylamine and again with dichloromethane, the resin is dried. Then 2.1 mmol of the 30 anchors prepared in Example 13 are added together with 3.15 mmol HOBt dissolved in 20 ml of dry DMF to the resin and 2.3 mmol diisopropylcarbodiimide added.

Under langsom gennemblånding tillades blandingen at reagere natten over ved stuetemperatur. Reaktionens fuldstændighed undersøges ved hjælp af ninhydrin-reaktionen (Kaiser-test).During slow mixing, the mixture is allowed to react overnight at room temperature. The completeness of the reaction is investigated by the ninhydrin reaction (Kaiser test).

35 Herefter frafiltreres harpiksen ved sugning, og der vaskes med DMF, hvorefter peptidet opbygges på harpiksen, hvorved man cyclisk gennemløber følgende trin: 14 DK 175111 B1 - Fmoc-beskyttelsesgruppen fraspaltes ned 20% plperidln i DMF, - harpiksen vaskes ned DMF, - Fnoc-aninosyren tilkobles under in situ-aktivering son 5 HOBt-ester under anvendelse af diisopropylcarbodiinid son aktiveringsreagens (2,1 mnol aninosyre, 3,15 mnol HOBt, 2,3 nnol diisopropylcarbodiinid), - harpiksen vaskes ned DMF.35 The resin is then filtered off by suction and washed with DMF, and the peptide builds up on the resin, thereby cyclically passing through the following steps: 14 - The amino acid is coupled during in situ activation of 5 HOBt ester using diisopropylcarbodiinide as activation reagent (2.1 mnole of amino acid, 3.15 mnole of HOBt, 2.3 nnole of diisopropylcarbodiinide), - the resin is washed down DMF.

Såfremt koblingen er ufuldstændig (Kaiser-test), 10 gentages koblingstrinnet.If the coupling is incomplete (Kaiser test), the coupling step is repeated.

Son sidekædebeskyttelsesgrupper anvendes tert.butyl for tyrosin og tert.butylthio for cystein.Other side chain protecting groups are used tert.butyl for tyrosine and tert.butylthio for cysteine.

Efter afsluttet syntese fraspaltes først Fmoc-beskyt-telsesgruppen, og herefter vaskes harpiksen ned i rækkefølge 15 DMF, dichlormethan, isopropanol, dichlornethan og tert.butyl--methylether, hvorefter der tørres under højvakuun. Der fås 2,4 g peptidharpiks. Fraspaltningen udføres ved stuetempera-tur med en blanding af trifluoreddikesyre/thioanisol/ethandi-thiol (80/15/5). Efter 2 timer frafiltreres der ved sugning 20 i tert.butyl-methylether, og det udfældede råpeptid fracentrifugeres, og det vaskes tre gange med tert.butyl-methylether. Fraspaltningen af tert.butylthio-beskyttelsesgruppen udføres ved hjælp af tributylphosphin i trifluorethanol/vand ved pH 7,3. S-H-peptidet ringsluttes med iod i en 60%'s 25 vandig eddikesyre, og peptidet oprenses ved hjælp af chroma-tografi på "Sephadex® LH 20" i methanol.After completion of the synthesis, the Fmoc protecting group is first decomposed and then the resin is washed down in order of DMF, dichloromethane, isopropanol, dichloromethane and tert-butyl-methyl ether and then dried under high vacuum. 2.4 g of peptide resin are obtained. The decomposition is carried out at room temperature with a mixture of trifluoroacetic acid / thioanisole / ethanedithiol (80/15/5). After 2 hours, suction 20 is filtered off in tert.butyl methyl ether and the precipitated crude peptide is centrifuged and washed three times with tert.butyl methyl ether. The cleavage of the tert-butylthio protecting group is carried out by means of tributylphosphine in trifluoroethanol / water at pH 7.3. The S-H peptide is cyclized with iodine in a 60% aqueous acetic acid and the peptide is purified by chromatography on "Sephadex® LH 20" in methanol.

Oxytocin-udbyttet er på 33%, hvor oxytocin er identisk ned en autentisk sammenligningsprøve. 1 35 'The oxytocin yield is 33%, where oxytocin is identical to an authentic comparison sample. 1 35 '

Claims (4)

1. Anvendelse af et diphenylroethanderivat med formlen I R2 R3Use of a diphenylroethane derivative of formula I R2 R3 5 XN/ γΒ γ9 γΐ γ2 r1“°"^^“ch“^^“y3 (I) γ7 γ6 γ5 γ4 10 i hvilken R1 betyder C^-g-alkyl eller eventuelt substitueret Cg«i4-aryl,5 XN / γΒ γ9 γΐ γ2 r1 "°" ^^ "ch" ^^ "y3 (I) γ7 γ6 γ5 γ4 10 in which R1 means C1-6 alkyl or optionally substituted C5-6 aryl, 15 R2 betyder en aminosyrerest, der er beskyttet med en svagt surt eller basisk fraspaltelig aminobeskyttelsesgruppe, R3 betyder hydrogen eller Ci„4-alkyl, Y1, Y2, Y3, Y4, Y5, Y6, Y7, Y8 og Y9 betyder hydrogen, C1.4-alkyl, C1_4-alkoxy eller -0-(CH2>n“C00H, hvor grupperne 20 kan være ens eller forskellige, idet én gruppe dog er -0-(CH2)n-COOH, og n betyder et helt tal fra 1 til 6, ved fastfasesyntese af peptidamider med formlen XIR 2 represents an amino acid residue protected by a weakly acidic or basic leaving amino protecting group, R 3 is hydrogen or C 1-4 alkyl, Y 1, Y 2, Y 3, Y 4, Y 5, Y 6, Y 7, Y 8 and Y 9 represents hydrogen, C 1. 4-alkyl, C 1-4 alkoxy or -O- (CH 2 to 6, by solid phase synthesis of peptidamides of formula XI 25 P-R2-NH-R3 (XI) , i hvilken P betyder en peptidrest af g < p+1 a-aminosyrer, og R2 og R3 er som defineret ovenfor. • 2. Fremgangsmåde til fremstilling af et peptidamid 30 med formlen XI, i hvlken P, R2 og R3 er defineret som i krav 1, ved en fastfasesyntese, kendetegnet ved, at man kobler et diphenylmethanderivat med formlen I ifølge krav 1, til en harpiks, fraspalter beskyttelsesgruppen for aminosyren R2, trinvis tilkobler q-p α-aminosyrer, soro er 35 midlertidigt beskyttet med baselabile eller mod svage syrer labile aminobeskyttelsesgrupper, eventuelt i form af deres DK 175111 B1 aktiverede derivater, og efter endt opbygning frigor peptidet ned formlen XI fra harpiksen ved behandling med en middel-stærk syre, idet man samtidig eller derefter ved hjælp af egnede foranstaltninger igen fraspalter midlertidigt indførte 5 sidekædebeskyttelsesgrupper. *P-R 2 -NH-R 3 (XI), in which P represents a peptide residue of g <p + 1 α-amino acids, and R 2 and R 3 are as defined above. A process for the preparation of a peptidamide 30 of formula XI, wherein the P, R2 and R3 are defined as in claim 1, by a solid phase synthesis characterized by coupling a diphenylmethane derivative of formula I to a resin , the protecting group of the amino acid R by treatment with a medium-strong acid, while temporarily or subsequently, by appropriate measures, 5 side chain protecting groups are temporarily peeled off again. *
DK199300143A 1987-04-08 1993-02-09 New substd. di:phenyl-methylamine derivs. DK175111B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3711866 1987-04-08
DE19873711866 DE3711866A1 (en) 1987-04-08 1987-04-08 SYNTHESIS OF PEPTIDAMIDES BY SOLID PHASE METHOD USING SAEURELABILE ANCHOR GROUPS
DK189388 1988-04-07
DK198801893A DK175624B1 (en) 1987-04-08 1988-04-07 Diphenylmethane derivatives, process for their preparation, and benzhydrols used in the process

Publications (3)

Publication Number Publication Date
DK14393D0 DK14393D0 (en) 1993-02-09
DK14393A DK14393A (en) 1993-02-09
DK175111B1 true DK175111B1 (en) 2004-06-07

Family

ID=32394757

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199300143A DK175111B1 (en) 1987-04-08 1993-02-09 New substd. di:phenyl-methylamine derivs.

Country Status (1)

Country Link
DK (1) DK175111B1 (en)

Also Published As

Publication number Publication date
DK14393D0 (en) 1993-02-09
DK14393A (en) 1993-02-09

Similar Documents

Publication Publication Date Title
EP1504022B1 (en) Process for the synthesis of peptide amides by side-chain attachment to a solid phase
US5124478A (en) Acid-labile anchor groups for the synthesis of peptide amides by a solid-phase method
DK175624B1 (en) Diphenylmethane derivatives, process for their preparation, and benzhydrols used in the process
STORY et al. Preparation of protected peptide amides using the Fmoc chemical protocol: Comparison of resins for solid phase synthesis 1
DK175111B1 (en) New substd. di:phenyl-methylamine derivs.
US5536815A (en) Cyclopropyl based O- and N- and S-protecting groups
EP0475184B1 (en) Process for the production of peptides by solid phase synthesis
EP0331073B1 (en) Benzhydrylamine derivatives
EP1654280B1 (en) Preparation of somatostatin peptides
EP0264802B1 (en) Synthesis of peptide-aminoalkyl amides and peptide hydrazides by the solid phase method
EP4365184A1 (en) Analysis method for peptide bound to carrier for liquid phase peptide synthesis
US5565606A (en) Synthesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method
CN117069797A (en) Liquid phase synthesis method of eptifibatide

Legal Events

Date Code Title Description
A0 Application filed
PUP Patent expired